Toxoplasma chorioretinitis
ICD-10 B58.1 is a billable code used to indicate a diagnosis of toxoplasma chorioretinitis.
Toxoplasma chorioretinitis is an ocular manifestation of Toxoplasma gondii infection, a protozoan parasite that can cause significant morbidity, particularly in immunocompromised individuals and during pregnancy. The condition is characterized by inflammation of the choroid and retina, leading to symptoms such as blurred vision, floaters, and in severe cases, vision loss. Toxoplasmosis is often acquired through ingestion of oocysts from contaminated food or water, or through vertical transmission from an infected mother to her fetus. Diagnosis typically involves clinical examination, serological testing for Toxoplasma antibodies, and imaging studies such as optical coherence tomography (OCT) or fundus photography. Treatment usually includes the use of pyrimethamine and sulfadiazine, along with folinic acid to mitigate the side effects of pyrimethamine. Early diagnosis and treatment are crucial to prevent complications and preserve vision.
Detailed notes on visual acuity, fundoscopic findings, and any imaging results.
Patients presenting with blurred vision, floaters, or acute vision loss.
Documentation must clearly indicate the relationship between Toxoplasma infection and ocular symptoms.
Comprehensive history of exposure, serological test results, and treatment plans.
Immunocompromised patients with systemic symptoms and ocular involvement.
Need to document any co-infections or underlying conditions affecting the immune system.
Used when a new patient presents with symptoms suggestive of Toxoplasma chorioretinitis.
Complete eye examination findings and any relevant history.
Ophthalmologists should document specific findings related to Toxoplasma infection.
Common symptoms include blurred vision, floaters, and in severe cases, vision loss. Patients may also experience eye pain or redness.
